NSIS-B:CPH
Novozymes A/S
DKK 449.00
arrow_upward
+1.47%(+6.50) 1D
Oct 14, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKK 444.30
High
DKK 449.00
Low
DKK 442.50
Mkt. cap
183.47B
Avg. vol.
567.49K
Volume
853.52K
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKK 444.30
High
DKK 449.00
Low
DKK 442.50
Mkt. cap
183.47B
Avg. vol.
567.49K
Volume
853.52K
52-wk high
DKK 465.00
52-wk low
DKK 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
Seeking Alpha
·
1 hour ago
S&P 500 sectors face strong historical tailwinds after mid-October close
ChartMill
·
1 hour ago
These S&P500 stocks are gapping in today's session
TradingView
·
2 hours ago
The Dow Jones Index Opens 0.26% Higher
Yahoo Finance
·
1 hour ago
This ETF Has Crushed the S&P 500 in 2026. Here's Why I Think It Still Has Room to Grow.
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
About Novozymes A/S